GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GH Research PLC (STU:1KA) » Definitions » Short-Term Debt

GH Research (STU:1KA) Short-Term Debt : €0.00 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is GH Research Short-Term Debt?

GH Research's Short-Term Debt for the quarter that ended in Dec. 2024 was €0.00 Mil.

GH Research Short-Term Debt Historical Data

The historical data trend for GH Research's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GH Research Short-Term Debt Chart

GH Research Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Short-Term Debt
Get a 7-Day Free Trial - - - - -

GH Research Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

GH Research Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

GH Research Short-Term Debt Related Terms

Thank you for viewing the detailed overview of GH Research's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

GH Research Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GH Research PLC (STU:1KA) » Definitions » Short-Term Debt
Comparable Companies
CRMD CAPR BCYC KROS NAGE ARVN TRVI ABUS IMTX SVRA VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
GHRS:USA
Address
Dawson Street, Joshua Dawson House, Dublin 2, IRL, D02 RY95
Website
https://www.ghres.com
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

GH Research Headlines

No Headlines